BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) shares traded down 1.4% during mid-day trading on Friday . The stock traded as low as $1.71 and last traded at $1.71. 4,718 shares traded hands during mid-day trading, a decline of 69% from the average session volume of 15,068 shares. The stock had previously closed at $1.74.
BeyondSpring Stock Down 1.4 %
The company’s fifty day moving average is $1.69 and its 200 day moving average is $1.96.
Institutional Trading of BeyondSpring
A hedge fund recently bought a new stake in BeyondSpring stock. Renaissance Technologies LLC bought a new stake in BeyondSpring Inc. (NASDAQ:BYSI – Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,500 shares of the company’s stock, valued at approximately $30,000. Institutional investors own 40.29% of the company’s stock.
BeyondSpring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
See Also
- Five stocks we like better than BeyondSpring
- ESG Stocks, What Investors Should Know
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Investing In Preferred Stock vs. Common Stock
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to Find Undervalued Stocks
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
